Sun Pharmaceutical Industries Ltd — Quarterly Results & Earnings

₹1757.20

+0.66%

Profit Growth YoY2.56%Latest quarter

Sales Growth YoY8.93%Latest quarter

Sales CAGR 5Y9.87%5 year compound

Profit CAGR 5Y23.78%5 year compound

📋

Quarterly Performance

YoY Profit Growth+2.56%

📈 Moderate growth

YoY Sales Growth+8.93%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

26.95%

EPS Growth 5Y

23.78%

Interest Coverage

Higher = safer debt servicing

57.54

ROE

16.86%

ROCE

20.21%

💡

Growth Analysis

Sun Pharmaceutical Industries Ltd reported YoY profit growth of 2.56% and revenue growth of 8.93% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 9.87% and profits at 23.78% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Sun Pharmaceutical Industries Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.